Skip to main content
. 2026 Jul 25;18(15):2399. doi: 10.3390/cancers18152399
3D three-dimensional
ABS American Brachytherapy Society
BT brachytherapy
CI confidence interval
COIN conformity index
CT computed tomography
CTCAE Common Terminology Criteria for Adverse Events
DHI dose homogeneity index
DMFS distant metastasis-free survival
DVH dose–volume histogram
EBRT external beam radiotherapy
EQD2 equivalent dose in 2-Gy fractions
FIGO International Federation of Gynecology and Obstetrics
GEC-ESTRO Groupe Européen de Curiethérapie–European Society for Radiotherapy and Oncology
GI gastrointestinal
GTV gross tumor volume
GU genitourinary
HDR high-dose-rate
HR hazard ratio
HR-CTV high-risk clinical target volume
IC/IS intracavitary–interstitial
ICRU International Commission on Radiation Units and Measurements
IGABT image-guided adaptive brachytherapy
IMRT intensity-modulated radiotherapy
IQR interquartile range
LACC locally advanced cervical cancer
LRFS local recurrence-free survival
MRI magnetic resonance imaging
OAR organ at risk
OS overall survival
OTT overall treatment time
PFS progression-free survival
PLA polylactic acid
RCS restricted cubic spline
ROC receiver operating characteristic
RRFS regional recurrence-free survival
SIB simultaneous integrated boost
VMAT volumetric modulated arc therapy